))
Ad Promo Review in Pharma - How Far is Too Far?
Manage episode 450491358 series 3506216
Contenido proporcionado por Darshan Kulkarni. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Darshan Kulkarni o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Katie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.
Key topics include:
- What is Ad Promo?
- Chevron decision's influence on FDA/FTC
- Should administrative agencies cite letters?
- Can the FDA establish rules after someone challenges them?
- Uncertainty of Compliance White Space
- Is regulatory medical advice now just seen as a risk?
138 episodios
Compartir
